Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01611090 |
|---|---|
| Brief Title: | A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma |
| First Submitted : | May 15, 2012 |
| First Submitted that Met QC Criteria : | May 31, 2012 |
| First Posted : | June 4, 2012 (Estimate) |
| Results First Submitted : | January 23, 2020 |
| Results First Submitted that Met QC Criteria : | February 20, 2020 |
| Results First Posted : | March 3, 2020 |
| Last Update Submitted that Met QC Criteria : | February 20, 2020 |
| Last Update Posted : | March 3, 2020 |